Transient inhibition of neddylation at neonatal stage evokes reversible cardiomyopathy and predisposes the heart to isoproterenol-induced heart failure.

Authors:
Jianqiu Zou
Jianqiu Zou
Sanford School of Medicine
United States
Jie Li
Jie Li
Peking University School of Nursing
TA
Beijing , China | China
Brian K Stansfield
Brian K Stansfield
Indiana University School of Medicine
India
Il-Man Kim
Il-Man Kim
Vascular Biology Center
Jinbao Liu
Jinbao Liu
Guangzhou Medical College
China
Jiliang Zhou
Jiliang Zhou
Indiana University School of Medicine
United States

Am J Physiol Heart Circ Physiol 2019 Jun 29;316(6):H1406-H1416. Epub 2019 Mar 29.

Vascular Biology Center, Medical College of Georgia, Augusta University , Augusta, Georgia.

Alterations in perinatal conditions (such as preterm birth) is linked to adult health and disease, in particular, the cardiovascular system. Neddylation, a novel posttranslational modification through which the ubiquitin-like protein NEDD8 is conjugated to protein substrates, has emerged as an important mechanism regulating embryonic cardiac chamber maturation. However, the importance of neddylation in postpartum cardiac development has not been investigated. Here, we aimed to determine whether transient, postnatal inhibition of neddylation has immediate and prolonged impact on the structure and function of the neonatal and adult hearts. Sprague-Dawley pups were given three intraperitoneal injections of MLN4924 (MLN), a specific neddylation inhibitor, at postnatal days (P)1, 3, and 5. Cardiac structure and function were temporally assessed during aging and after 2 wk of isoproterenol (ISO) infusion in adulthood. MLN treatment resulted in modest reduction of neddylated proteins in neonatal hearts. The MLN-treated rats developed cardiac hypertrophy and dysfunction by P7, which was accompanied by significantly reduced cardiomyocyte proliferation. At 3 mo of age, cardiac contractile function was restored in MLN-treated rats, but MLN-treated hearts displayed hypertrophic phenotype. Whereas ISO infusion triggered compensatory cardiac hypertrophy without impairing cardiac contractility in the control rats, the MLN-treated rats displayed a similar degree of hypertrophy, which quickly progressed to decompensation with ventricular wall thinning, chamber dilatation, and reduced ejection fraction as well as exacerbated pathological cardiac remodeling. Our findings suggest that neddylation is required for postnatal cardiac development and that perturbation of neddylation during development predisposes adult hearts to cardiac failure under stress conditions. Our study demonstrates that perinatal perturbation of neddylation induces cardiomyopathy, impairs postnatal cardiac development, and increases susceptibility to catecholamine-induced cardiac dysfunction. The results reveal a previously unappreciated role of neddylation in postnatal cardiac maturation and call for close monitoring for the potential cardiotoxicity of MLN4924 (pevonedistat) and other agents that modify neddylation, especially in pregnant women and preadolescents.

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpheart.00806.2018DOI Listing
June 2019
1 Read
3.838 Impact Factor

Publication Analysis

Top Keywords

cardiac
13
postnatal cardiac
12
mln-treated rats
12
cardiac development
12
neddylation
10
iso infusion
8
cardiac hypertrophy
8
perturbation neddylation
8
rats mln-treated
8
inhibition neddylation
8
structure function
8
adult hearts
8
postnatal
5
mln-treated hearts
4
restored mln-treated
4
age cardiac
4
cardiac contractile
4
contractile function
4
function restored
4
hearts displayed
4

References

(Supplied by CrossRef)

Similar Publications